Condition
Terminal Renal Insufficiency
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Clinical Trials (2)
Showing 2 of 2 trials
NCT05689801Not ApplicableUnknownPrimary
Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life
NCT04367714Unknown
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19
Showing all 2 trials